Effect of dopamine D4 receptor agonists on sleep architecture in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 63, Issue , 2015, Pages 6-13

  Nakazawa, Shunsuke ^a   Nakamichi, Keiko ^a   Imai, Hideaki ^a   Ichihara, Junji ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

EEG; NREM; REM; Sleep; Wakefulness

Indexed keywords

5 [(3,6 DIHYDRO 4 PHENYL 1 (2H) PYRIDINYL)METHYL] 2 METHYL 4 PYRIMIDINAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; N (3 METHYLPHENYL) 4 (2 PYRIDINYL) 1 PIPERIDINE ACETAMIDE; UNCLASSIFIED DRUG; 2-(3',4',5',6'-TETRAHYDRO-2'H-(2,4') BIPYRIDINYL-1'-YL)-N-M-TOLYL-ACETAMIDE; ACETAMIDE DERIVATIVE; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; RO 10-5824;

ADULT; ANIMAL EXPERIMENT; AROUSAL; ARTICLE; CONTROLLED STUDY; GAMMA RHYTHM; MALE; NONHUMAN; NONREM SLEEP; RAT; REM SLEEP; SLEEP; SLEEP TIME; THETA RHYTHM; WAKEFULNESS; AGONISTS; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; REACTION TIME; TELEMETRY; WISTAR RAT;

ACETAMIDES; ANIMALS; BRAIN WAVES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; MALE; PYRIDINES; PYRIMIDINES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, DOPAMINE D4; SLEEP; TELEMETRY; WAKEFULNESS;

EID: 84930671859     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.05.006     Document Type: Article

References (50)

1. Ahnaou A., Ver Donck L., Drinkenburg W.H. Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: evidence from sleep-wake EEG in rodents. Behav Brain Res 2014, 270:56-67. 10.1016/j.bbr.2014.05.003.
2. Azdad K., Piet R., Poulain D.A., Oliet S.H. Dopamine D4 receptor-mediated presynaptic inhibition of GABAergic transmission in the rat supraoptic nucleus. J Neurophysiol 2003, 90(2):559-565.
3. Baskerville T.A., Allard J., Wayman C., Douglas A.J. Dopamine-oxytocin interactions in penile erection. Eur J Neurosci 2009, 30(11):2151-2164. 10.1111/j.1460-9568.2009.06999.x.
4. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 2011, 63(1):182-217. 10.1124/pr.110.002642.
5. Berridge C.W., Devilbiss D.M., Andrzejewski M.E., Arnsten A.F., Kelley A.E., Schmeichel B., et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 2006, 60(10):1111-1120.
6. Billiard M. Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat 2008, 4(3):557-566.
7. Browman K.E., Curzon P., Pan J.B., Molesky A.L., Komater V.A., Decker M.W., et al. A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats. Pharmacol Biochem Behav 2005, 82(1):148-155.
8. Cavas M., Navarro J.F. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(4):668-678.
9. Erlij D., Acosta-García J., Rojas-Márquez M., González-Hernández B., Escartín-Perez E., Aceves J., et al. Dopamine D4 receptor stimulation in GABAergic projections of the globus pallidus to the reticular thalamic nucleus and the substantia nigra reticulata of the rat decreases locomotor activity. Neuropharmacology 2012, 62(2):1111-1118. 10.1016/j.neuropharm.2011.11.001.
10. Florán B., Florán L., Erlij D., Aceves J. Activation of dopamine D4 receptors modulates [3H]GABA release in slices of the rat thalamic reticular nucleus. Neuropharmacology 2004, 46(4):497-503.
11. Gasca-Martinez D., Hernandez A., Sierra A., Valdiosera R., Anaya-Martinez V., Floran B., et al. Dopamine inhibits GABA transmission from the globus pallidus to the thalamic reticular nucleus via presynaptic D4 receptors. Neuroscience 2010, 169(4):1672-1681. 10.1016/j.neuroscience.2010.05.048.
12. Gazi L., Bobirnac I., Danzeisen M., Schüpbach E., Bruinvels A.T., Geisse S., et al. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Br J Pharmacol 1998, 124(5):889-896.
13. Gazi L., Bobirnac I., Danzeisen M., Schüpbach E., Langenegger D., Sommer B., et al. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells. Br J Pharmacol 1999, 128(3):613-620.
14. Gazi L., Schoeffter P., Nunn C., Croskery K., Hoyer D., Feuerbach D. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Naunyn Schmiedebergs Arch Pharmacol 2000, 361(5):555-564.
15. González S., Rangel-Barajas C., Peper M., Lorenzo R., Moreno E., Ciruela F., et al. Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry 2012, 17(6):650-662. 10.1038/mp.2011.93.
16. Govindaiah G., Wang T., Gillette M.U., Crandall S.R., Cox C.L. Regulation of inhibitory synapses by presynaptic D[U+2084] dopamine receptors in thalamus. J Neurophysiol 2010, 104(5):2757-2765. 10.1152/jn.00361.2010.
17. Gruner J.A., Marcy V.R., Lin Y.G., Bozyczko-Coyne D., Marino M.J., Gasior M. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep 2009, 32(11):1425-1438.
18. Hauser R.A., Gauger L., Anderson W.M., Zesiewicz T.A. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000, 15(4):658-663.
19. Khan Z.U., Gutiérrez A., Martín R., Peñafiel A., Rivera A., De La Calle A. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol 1998, 402(3):353-371.
20. Kügler F., Sihver W., Ermert J., Hübner H., Gmeiner P., Prante O., et al. Evaluation of 18F-labeled benzodioxine piperazine-based dopamine D4 receptor ligands: lipophilicity as a determinate of nonspecific binding. J Med Chem 2011, 54(24):8343-8352. 10.1021/jm200762g.
21. Lagos P., Scorza C., Monti J.M., Jantos H., Reyes-Parada M., Silveira R., et al. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 1998, 8(2):113-120.
22. Leopoldo M., Selivanova S.V., Müller A., Lacivita E., Schetz J.A., Ametamey S.M. In vitro and in vivo evaluation of N-{2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl}-3-[(11) C]methoxybenz-amide, a positron emission tomography (PET) radioligand for dopamine D4 receptors, in rodents. Chem Biodivers 2014, 11(9):1298-1308. 10.1002/cbdv.201400178.
23. Li D., Sham P.C., Owen M.J., He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 2006, 15(14):2276-2284.
24. Michaelides M., Pascau J., Gispert J.D., Delis F., Grandy D.K., Wang G.J., et al. Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Eur J Neurosci 2010, 32(4):668-676. 10.1111/j.1460-9568.2010.07319.x.
25. Monti J.M., Jantos H. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res 2008, 172:625-646. 10.1016/S0079-6123(08)00929-1.
26. Monti J.M., Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 2007, 11(2):113-133.
27. Monti J.M., Hawkins M., Jantos H., D'Angelo L., Fernández M. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology (Berl) 1988, 95(3):395-400.
28. Monti J.M., Jantos H., Fernández M. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 1989, 169(1):61-66.
29. Monti J.M., Fernández M., Jantos H. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology 1990, 3(3):153-162.
30. Moreland R.B., Patel M., Hsieh G.C., Wetter J.M., Marsh K., Brioni J.D. A-412997 is a selective dopamine D4 receptor agonist in rats. Pharmacol Biochem Behav 2005, 82(1):140-147.
31. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996, 381(6579):245-248.
32. Murai T., Nakako T., Ikeda K., Ikejiri M., Ishiyama T., Taiji M. Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone. Behav Brain Res 2014, 261:26-30. 10.1016/j.bbr.2013.11.036.
33. Murai T., Nakamichi K., Shimizu I., Ikeda K. Lurasidone suppresses rapid eye movement sleep and improves sleep quality in rats. J Pharmacol Sci 2014, 126(2):164-167.
34. Murck H., Frieboes R.M., Antonijevic I.A., Steiger A. Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men. Psychopharmacology (Berl) 2001, 155(2):187-192.
35. Newman-Tancredi A., Heusler P., Martel J.C., Ormière A.M., Leduc N., Cussac D. Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells. Int J Neuropsychopharmacol 2008, 11(3):293-307.
36. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 2002, 67(1):53-83.
37. Ongini E., Bonizzoni E., Ferri N., Milani S., Trampus M. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 1993, 266(2):726-731.
38. Paterson L.M., Wilson S.J., Nutt D.J., Hutson P.H., Ivarsson M. A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. Psychopharmacology (Berl) 2007, 191(4):943-950.
39. Pinault D. The thalamic reticular nucleus: structure, function and concept. Brain Res Brain Res Rev 2004, 46(1):1-31.
40. Powell S.B., Paulus M.P., Hartman D.S., Godel T., Geyer M.A. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology 2003, 44(4):473-481.
41. Qu W.M., Xu X.H., Yan M.M., Wang Y.Q., Urade Y., Huang Z.L. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci 2010, 30(12):4382-4389. 10.1523/JNEUROSCI.4936-09.2010.
42. Steriade M. Sleep, epilepsy and thalamic reticular inhibitory neurons. Trends Neurosci 2005, 28(6):317-324.
43. Tejas-Juárez J.G., Cruz-Martínez A.M., López-Alonso V.E., García-Iglesias B., Mancilla-Díaz J.M., Florán-Garduño B., et al. Stimulation of dopamine D4 receptors in the paraventricular nucleus of the hypothalamus of male rats induces hyperphagia: involvement of glutamate. Physiol Behav 2014, 133:272-281. 10.1016/j.physbeh.2014.04.040.
44. Trampus M., Ferri N., Adami M., Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 1993, 235(1):83-87.
45. Wang X., Zhong P., Yan Z. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 2002, 22(21):9185-9193.
46. Wang X., Zhong P., Gu Z., Yan Z. Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex. J Neurosci 2003, 23(30):9852-9861.
47. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21(5):1787-1794.
48. Woolley M.L., Waters K.A., Reavill C., Bull S., Lacroix L.P., Martyn A.J., et al. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat. Behav Pharmacol 2008, 19(8):765-776. 10.1097/FBP.0b013e32831c3b06.
49. Zawilska J.B., Rosiak J., Berezińska M., Nowak J.Z. L-745,870 suppresses the nighttime serotonin N-acetyltransferase activity in chick retina: in vivo evidence for agonist activity at D4-dopamine receptors. J Neural Transm 2003, 110(3):219-227.
50. Zhong P., Yan Z. Distinct physiological effects of dopamine D4 receptors on prefrontal cortical pyramidal neurons and fast-spiking interneurons. Cereb Cortex 2014, 10.1093/cercor/bhu190.